Targeting β2-adrenoceptors for neuroprotection after cerebral ischemia: Is inhibition or stimulation best?

Anesthesia and Analgesia

Volumn 108, Issue 1, 2009, Pages 3-5

  Culmsee, Carsten ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 3 ADRENERGIC RECEPTOR; BUTOXAMINE; CLENBUTEROL; SALMETEROL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; NEUROPROTECTIVE AGENT;

ASTROCYTE; AUTORADIOGRAPHY; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; BRAIN DYSFUNCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN VASOSPASM; CELL PROLIFERATION; DRUG INHIBITION; DRUG MECHANISM; DRUG TARGETING; EDITORIAL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICROGLIA; NERVE CELL; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; ANIMAL; DISEASE MODEL; DRUG EFFECT; GENETICS; HUMAN; MOUSE; MOUSE MUTANT; NOTE;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BRAIN INJURIES; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, KNOCKOUT; NEUROPROTECTIVE AGENTS; RECEPTORS, ADRENERGIC, BETA-2;

EID: 58749093926     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e31818db6f6     Document Type: Editorial

References (25)

1. Culmsee C, Krieglstein J. Mechanisms of neuronal degeneration after ischemic stroke-emerging targets for novel therapeutic strategies. Drug Discov Today Dis Mech 2005;2:463-70
2. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003;4:399-415
3. Han RQ, Ouyang YB, Xu L, Agrawal R, Patterson AJ, Giffard RG. Postischemic brain injury is attenuated in mice lacking the -2-adrenergic receptor. Anesth Analg 2009;108:280-7
4. Kato H, Kawaguchi M, Inoue S, Hirai K, Furuya H. The effects of -2-adrenoceptor antagonists on proinflammatory cytokine concentrations after subarachnoid hemorrhage in rats. Anesth Analg 2009;108:288-95
5. Hein L. Adrenoceptors and signal transduction in neurons. Cell Tissue Res 2006;326:541-51
6. Summers RJ, Papaioannou M, Harris S, Evans BA. Expression of beta3-adrenoceptor messenger-RNA in rat-brain. Br J Pharmacol 1995;116:2547-8
7. Pazos A, Probst A, Palacios JM. Beta-Adrenoceptor subtypes in the human brain-autoradiographic localization. Brain Res 1985;358:324-8
8. Nicholas AP, Pieribone VA, Hokfelt T. Cellular-localization of messenger-RNA for beta-1 and beta-2-adrenergic receptors in rat brain - an in-situ hybridization study. Neuroscience 1993;56:1023-39
9. Rainbow TC, Parsons B, Wolfe BB. Quantitative autoradiography of beta-1-adrenergic and beta-2-adrenergic receptors in rat brain. Proc Natl Acad Sci USA 1984;81:1585-9
10. Morin D, Sapena R, Zini R, Onteniente B, Tillement JP. Characterization of -adrenergic receptors of freshly isolated astrocytes and neurons from rat brain. Life Sci 2008;60:315-24
11. Sutin J, Shao YP. Resting and reactive astrocytes express adrenergic receptors in the adult-rat brain. Brain Res Bull 1992;29:277-84
12. Mantyh PW, Rogers SD, Allen CJ, Catton MD, Ghilardi JR, Levin LA, Maggio JE, Vigna SR. Beta2-Adrenergic receptors are expressed by glia in-vivo in the normal and injured central nervous system in the rat, rabbit, and human. J Neurosci 1995;15:152-64
13. Fujita H, Tanaka J, Maeda N, Sakanaka M. Adrenergic agonists suppress the proliferation of microglia through beta 2-adrenergic receptor. Neurosci Lett 1998;242:37- 40
14. Semkova I, Schilling M, Henrich-Noack P, Rami A, Krieglstein J. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res 1996;717:44-54
15. Zhu Y, Culmsee C, Semkova I, Krieglstein J. Stimulation of beta2-adrenoceptors inhibits apoptosis in rat brain after transient forebrain ischemia. J Cereb Blood Flow Metab 1998;18:1032-9
16. Culmsee C, Stumm RK, Schafer MKH, Weihe E, Krieglstein J. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur J Pharmacol 1999;379:33-45
17. Zhu Y, Krieglstein J. -2-Adrenoceptor agonist clenbuterol causes NGF expression and neuroprotection. CNS Drug Rev 1999;5:347-64
18. Junker V, Becker A, Huhne R, Zembatov M, Ravati A, Culmsee C, Krieglstein J. Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection. Eur J Pharmacol 2002;446:25-36
19. Semkova I, Krieglstein J. Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors. Brain Res Rev 1999;30:176-88
20. Culmsee C, Semkova I, Krieglstein J. NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study. Neurochem Int 1999;35:47-57
21. Lowenstein DH, Chan PH, Miles MF. The stress protein response in cultured neurons-characterization and evidence for a protective role in excitotoxicity. Neuron 1991;7:1053-60
22. Yenari MA, Fink SL, Sun GH, Chang LK, Patel MK, Kunis DM, Onley D, Ho DY, Sapolsky RM, Steinberg GK. Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann Neurol 1998;44:584-91
23. Vogel P, Dux E, Wiessner C. Effect of heat shock on neuronal cultures: importance of protein synthesis and HSP72 induction for induced tolerance and survival. Metab Brain Dis 1997;12:203-17
24. Hodges-Savola C, Rogers SD, Ghilardi JR, Timm DR, Mantyh PW. Beta-Adrenergic receptors regulate astrogliosis and cell proliferation in the central nervous system in vivo. Glia 1996;17:52-62
25. Li LZ, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, Pardo AC, Nodin C, Stahlberg A, Aprico K, Larsson K, Yabe T, Moons L, Fotheringham A, Davies I, Carmeliet P, Schwartz JP, Pekna M, Kubista M, Blomstrand F, Maragakis N, Nilsson M, Pekny M. Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 2008;28:468-81